3,4-dihydroxyphenylacetic acid has been researched along with paraquat in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Baggs, RB; Cory-Slechta, DA; Richfield, EK; Tank, AW; Thiruchelvam, M | 1 |
| Cory-Slechta, DA; Di Monte, DA; Langston, JW; Manning-Bog, AB; McCormack, AL; Thiffault, C; Thiruchelvam, M | 1 |
| Fujimaru, S; Matsubara, K; Ohtaki, K; Saito, O; Shimizu, K; Shiono, H | 1 |
| Kadota, S; Li, X; Matsumoto, K; Murakami, Y; Tezuka, Y; Wu, Y | 1 |
| Ali, SF; Charlton, CG; Jiao, Y; Lamango, NS; Lee, ES; Oriaku, ET; Schmued, L; Shepherd, KR; Soliman, KF | 1 |
| Biedka, I; Bortel, A; Dabrowska, J; Kuter, K; Nowak, P; Ossowska, K; Rommelspacher, H; Schulze, G; Smiałowska, M; Wardas, J; Wierońska, J; Zieba, B | 1 |
| Cavada, C; Cuadrado, A; de Sagarra, MR; Rojo, AI | 1 |
| Bajo-Grañeras, R; Ganfornina, MD; Martín-Tejedor, E; Sanchez, D | 1 |
| Beck, M; Botham, PA; Breckenridge, CB; Butt, M; Cook, AR; Mathews, JM; Minnema, D; Smith, LL; Sturgess, NC; Tisdel, MO; Travis, KZ; Wolf, JC; Zadory, D | 1 |
| Bogo, MR; Bonan, CD; Bortolotto, JW; Christoff, RR; Cognato, GP; Kist, LW; Leite, CE; Roesler, LN; Vianna, MR | 1 |
| Chen, YB; Cui, YL; Wang, YQ; Wu, JR | 1 |
11 other study(ies) available for 3,4-dihydroxyphenylacetic acid and paraquat
| Article | Year |
|---|---|
The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Carrier Proteins; Cell Count; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Administration Schedule; Drug Synergism; Glial Fibrillary Acidic Protein; Gliosis; Injections, Intraperitoneal; Lung; Male; Maneb; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Nucleus Accumbens; Paraquat; Parkinson Disease, Secondary; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2000 |
Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Dopamine; Environmental Exposure; gamma-Aminobutyric Acid; Gliosis; Herbicides; Homovanillic Acid; Humans; Injections, Intraperitoneal; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Parkinsonian Disorders; Risk Factors; Substantia Nigra; Tyrosine 3-Monooxygenase | 2002 |
Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Extracellular Space; Glutamic Acid; Herbicides; Homovanillic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Nerve Tissue Proteins; Neuroprotective Agents; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Paraquat; Parkinsonian Disorders; Quinoxalines; Rats; Rats, Wistar; Selegiline | 2003 |
Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Dopamine; Fungicides, Industrial; Herbicides; Immunohistochemistry; Levodopa; Male; Maneb; Mice; Mice, Inbred C57BL; Motor Activity; Neostriatum; Nerve Degeneration; Neuroprotective Agents; Paraquat; Parkinson Disease, Secondary; Phytotherapy; Plant Roots; Polygonum; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |
The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Dopamine; Drug Synergism; Herbicides; Homovanillic Acid; Humans; Male; Methylation; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neurotoxins; Paraquat | 2006 |
Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Cerebral Cortex; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Herbicides; Homovanillic Acid; Immunohistochemistry; Male; Nerve Degeneration; Neurons; Paraquat; Parkinsonian Disorders; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2006 |
Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Administration, Inhalation; Administration, Intranasal; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Administration Schedule; Herbicides; Insecticides; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Degeneration; Neurons; Paraquat; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra | 2007 |
Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Apolipoproteins D; Apoptosis; Astrocytes; Brain; Cells, Cultured; Cerebral Cortex; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Flow Cytometry; Gene Expression Regulation; Herbicides; Homovanillic Acid; Humans; Hypokinesia; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Neurons; Paraquat; Signal Transduction; Thiobarbituric Acid Reactive Substances | 2011 |
Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Basal Ganglia; Cell Death; Dopamine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drug Administration Schedule; Half-Life; Herbicides; Homovanillic Acid; Injections, Intraperitoneal; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Microglia; MPTP Poisoning; Nerve Degeneration; Paraquat; Substantia Nigra; Tyrosine 3-Monooxygenase | 2013 |
Long-term exposure to paraquat alters behavioral parameters and dopamine levels in adult zebrafish (Danio rerio).
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fish Proteins; Gene Expression Regulation; Herbicides; Paraquat; Polymerase Chain Reaction; Tyrosine 3-Monooxygenase; Zebrafish; Zebrafish Proteins | 2014 |
A novel idea for establishing Parkinson's disease mouse model by intranasal administration of paraquat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Intranasal; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Male; Mice; Mice, Inbred C57BL; Paraquat; Parkinsonian Disorders; Poloxamer | 2021 |